Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Lansoprazole and Domperidone Combination in GERD
NCT02958046Phase 4Completed
- Sponsor
- Neutec Group
- Start
- Jan 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lansoprazole, domperidone in gastroesophageal reflux disease (GERD), sponsored by Neutec Group. Started Jan 2014; status: completed.
02
Drugs
lansoprazoledomperidone
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02958046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02958046.